Edison Talks- Interview with Jean-Philippe Milon, CEO of Quantum Genomics

Edison Talks- Interview with Jean-Philippe Milon, CEO of Quantum Genomics

00:00
 
00:00
 
 
 
 
 
 
 
 

In this episode of Edison Talks, Edison’s director of research for North America, Maxim Jacobs, has an in-depth discussion with the CEO of Quantum Genomics, Jean-Philippe Milon. They cover Quantum Genomics’ programs in hypertension and heart failure, the data so far and the road ahead.

01:02 Overview of Quantum Genomics 02:32 How firibastat works 04:26 The positive NEW HOPE trial data in hypertension 08:46 The Phase III program for firibastat in hypertension and the design of the FRESH study 14:03 The recent Biolab Sanus deal and the licensing strategy going forward 20:15 The program in heart failure 26:31 The key upcoming milestones

Latest

news

Milosz Papst in Investors’ Chronicle

news

Neil Shah in AskTraders

news

Jonathan Day in AskTraders

news

Milosz Papst in Investors’ Chronicle

Short monitor- A number of new additions

Continue Reading
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.